{"entity":{"id":"paper-irzaldy-hpv-vaccination-cin2-slovenia-lanepe-2025","kind":"paper","name":"Impact of Slovenia's national HPV vaccination programme for girls on cytology screening performance and CIN2+ incidence: five-year population-based results","aka":[],"tldr":"In Slovenia's cervical screening registry, women in the first birth cohorts offered HPV vaccination as girls had 42% fewer high-grade cervical lesions than the cohort just before them, even though only about half were vaccinated.","summary":"A cohort study using Slovenia's cervical screening registry, comparing women born 1998 to 2001, the first cohort targeted by the preadolescent HPV vaccination programme, with women born 1994 to 1997, the last cohort not targeted, in cytology screening, to which women in Slovenia are invited from age 20.","asOf":"2026-11-11","links":[{"label":"DOI","url":"https://doi.org/10.1016/j.lanepe.2024.101203"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/39834615/"}],"tags":[],"related":[],"cancers":["cervical"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"journal":"The Lancet Regional Health: Europe","year":2025,"doi":"10.1016/j.lanepe.2024.101203","pmid":"39834615","authors":"Irzaldy A, Jerman T, de Kok IMCM, et al., Ivanuš U","paperType":"observational","findings":["Annual quadrivalent vaccine coverage in the targeted cohort was between 48.7% and 55.2%.","CIN2+ incidence was lower in the vaccine-targeted cohort (incidence rate ratio 0.58, 95% CI 0.49 to 0.69).","The CIN2+ detection rate was 0.31% (79 of 25,185) against 0.55% (165 of 30,181), and the positive predictive value of an abnormal smear fell from 39.0% to 26.8%."],"whatItMeans":"Vaccination is already reducing precancer in young Slovenian women, and the authors argue that screening needs to change for vaccinated cohorts.","caveats":["Compares birth cohorts rather than vaccinated and unvaccinated individuals; funded by EU Horizon 2020."]},"route":"/key-papers/paper-irzaldy-hpv-vaccination-cin2-slovenia-lanepe-2025/","neighbours":{"cancer":[{"id":"cervical","kind":"cancer","name":"Cervical cancer","route":"/cancers/cervical/"}],"institution":[{"id":"slovenia-ministry-of-health","kind":"institution","name":"Ministrstvo za zdravje, Slovenia","route":"/institutions/slovenia-ministry-of-health/"}]}}